Related Experiment Video

Updated: Aug 29, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

Issues to consider when attempting to achieve the American Diabetes Association clinical quality requirement for

Patrick J Twomey1, Anthony S Wierzbicki, Timothy M Reynolds

  • 1Specialist Registrar in Clinical Biochemistry, Edinburgh Royal Infirmary, Edinburgh, UK. p.twomey@ed.ac.uk

Current Medical Research and Opinion
|December 23, 2003
PubMed

Insights

Clinicians must understand haemoglobin A1c (A1C) test limitations, including intra-individual variation, which impacts diabetes management. More frequent A1C monitoring and laboratory quality controls are recommended for precise glycaemic control assessment.

Area of Science:

  • Clinical Chemistry
  • Endocrinology
  • Diabetes Mellitus Research

Background:

  • Diabetes mellitus management relies on monitoring glycaemic control using haemoglobin A1c (A1C).
  • Understanding A1C measurement limitations is crucial for effective clinical practice.
  • Current guidelines from the American Diabetes Association emphasize A1C's role but require awareness of its variability.

Purpose of the Study:

  • To elucidate the limitations of haemoglobin A1c (A1C) testing in diabetes mellitus management.
  • To highlight the impact of analytical and biological variation on A1C results.
  • To provide recommendations for improving the precision and reliability of A1C monitoring.

Main Methods:

  • Review of existing literature on A1C measurement variability.
  • Analysis of factors contributing to bias, including DCCT-aligned methods.
  • Discussion of intra-individual variation as a primary source of A1C fluctuation.

Main Results:

  • Intra-individual variation is identified as the principal factor affecting A1C results in stable patients.
  • Bias between DCCT-aligned methods and analytical variation also contribute to A1C measurement uncertainty.
  • Frequent A1C monitoring may be necessary to achieve precise glycaemic control assessment.

Conclusions:

  • Clinicians need a deeper understanding of A1C test limitations for optimal diabetes care.
  • Laboratories should implement robust quality control measures, including internal quality control and 'Delta check' criteria.
  • Adherence to enhanced quality assurance procedures will improve the accuracy of A1C results for clinical decision-making and audits.

Related Concept Videos

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...